AMN Healthcare Files 8-K on Operations and Personnel Changes

Ticker: AMN · Form: 8-K · Filed: 2024-10-01T00:00:00.000Z

Sentiment: neutral

Topics: operations, personnel, financial-condition

Related Tickers: AMN

TL;DR

AMN Healthcare dropped an 8-K detailing financial results and officer changes. Check it out.

AI Summary

AMN Healthcare Services, Inc. filed an 8-K on October 1, 2024, reporting on results of operations, financial condition, and changes in directors and officers. The filing also includes financial statements and exhibits, with the company's principal executive offices located at 2999 Olympus Boulevard, Suite 500, Dallas, Texas.

Why It Matters

This 8-K filing provides updates on AMN Healthcare's financial performance and any significant changes in its leadership or board of directors, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — This is a routine 8-K filing reporting on operational results and personnel, not indicating any immediate or significant new risks.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates 'Results of Operations and Financial Condition' are being reported, but the specific details of these results are not provided in the excerpt.

Were there any changes in directors or officers reported?

Yes, the filing explicitly mentions 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item of information.

What is the primary business of AMN Healthcare Services, Inc. according to the filing?

The filing lists the Standard Industrial Classification as 'SERVICES-HELP SUPPLY SERVICES [7363]'.

When was the earliest event reported in this 8-K?

The date of the earliest event reported is October 1, 2024.

Where are AMN Healthcare's principal executive offices located?

AMN Healthcare's principal executive offices are located at 2999 Olympus Boulevard, Suite 500, Dallas, Texas 75019.

From the Filing

0000950142-24-002477.txt : 20241001 0000950142-24-002477.hdr.sgml : 20241001 20241001082355 ACCESSION NUMBER: 0000950142-24-002477 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241001 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 241341397 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 eh240538228_8k.htm FORM 8-K FORM 8-K false 0001142750 0001142750 2024-10-01 2024-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 1, 2024   AMN HEALTHCARE SERVICES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-16753 06-1500476 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)       2999 Olympus Boulevard , Suite 500 Dallas , Texas 75019 (Address of principal executive offices) (Zip Code)   ( 866 ) 871-8519 (Registrant’s Telephone Number, Including Area Code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   AMN   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 2.02. Results of Operations and Financial Condition.   On October 1, 2024, AMN Healthcare Services, Inc. (the “Company”) issued a press release reaffirming the Company’s financial guidance for the third quarter 2024 and announcing the departure of the Company’s Chief Financial Officer as described below. A

View on Read The Filing